Bioxytran Investor Relations Material
Latest events
Q2 2025
20 Aug, 2025
Q1 2025
14 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Bioxytran Inc
Access all reports
Bioxytran Inc. is a biotechnology company focused on developing therapies for fibrotic and viral diseases. The company specializes in glycovirology, using carbohydrate-based drugs to target viral infections and inflammatory conditions. Its research includes treatments for diseases such as COVID-19 and pulmonary fibrosis, aiming to improve oxygen delivery and tissue regeneration. The company is headquartered in Needham, Massachusetts, and its shares are listed on the OTCQB.
)
)
)